Annals of Translational Medicine
The Annals of Translational Medicine (Ann Transl Med; ATM; Print ISSN 2305-5839; Online ISSN 2305-5847) is an international, peer-reviewed Open Access journal featuring original and observational investigations in the broad fields of laboratory, clinical, and public health research, aiming to provide practical up-to-date information in significant research from all subspecialties of medicine and to broaden the readers’ vision and horizon from bench to bed and bed to bench. It is published quarterly (April 2013- Dec 2013), monthly (Jan 2014 - Dec 2014), biweekly (March 2015-) and openly distributed worldwide.
Annals of Translational Medicine is indexed in PubMed in Sept 2014 and in SCIE in 2018 (2020 Impact Factor: 3.932). Specific areas of interest include, but not limited to, multimodality therapy, epidemiology, biomarkers, imaging, biology, pathology, and technical advances related to medicine. Submissions describing preclinical research with potential for application to human disease, and studies describing research obtained from preliminary human experimentation with potential to further the understanding of biological mechanism underlying disease are encouraged. Also warmly welcome are studies describing public health research pertinent to clinic, disease diagnosis and prevention, or healthcare policy.
With a focus on interdisciplinary academic cooperation, ATM aims to expedite the translation of scientific discovery into new or improved standards of management and health outcomes practice.
Essential Science Indicators Field
Review policy on Publons
- Does not allow reviews to be publicly displayed
- Only allows reviewers to display the journal they reviewed for
Interested in reviewing for this journal?
We can put registered members of Publons' reviewer community in touch with partnered journals they would like to review for. Register now to let Annals of Translational Medicine know you want to review for them.
Editorial board members on Publons
Publons users have indicated that they sit on Annals of Translational Medicine's editorial board but we are unable to verify these claims.